Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

ELMORE PATENT LAW GROUP, PC

WESTFORD, MA US

1. 20110034898 Stable Formulation of a Therapeutic Protein 02-10-2011
2. 20110033549 Stabilisation of Proteins - dry composition for use in therapy or diagnosis obtainable by drying an aqueous composition comprising a protein and one or 02-10-2011
3. 20110033420 MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS 02-10-2011
4. 20110021729 Methods of Purifying Poly(Styrene-co-Maleic Anhydride/Acid) 01-27-2011
5. 20110015156 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS 01-20-2011
6. 20110015088 BIOCATALYTIC SOLGEL MICROARRAYS - system and method for conducting high-throughput interactions between test compositions and analytes 01-20-2011
7. 20110008288 HEPATITIS C VIRUS INHIBITORS - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 01-13-2011
8. 20110008286 NOVEL PROLINE SUBSTITUTED CYCLOSPORIN ANALOGUES 01-13-2011
9. 20110008285 NOVEL CYCLOSPORIN ANALOGUES - novel cyclosporin analogue compounds pharmaceutical compositions comprising these compounds and methods of using these 01-13-2011
10. 20110008284 NOVEL CLYCLOSPORIN ANALOGUES - novel cyclosporin analogue compounds pharmaceutical compositions comprising these compounds and methods of using these 01-13-2011
11. 20110008248 Peptide Antagonists of TGF-Beta Family Members and Therapeutic Uses Thereof 01-13-2011
12. 20110003828 PRODRUGS OF NH-ACIDIC COMPOUNDS - method of sustained delivery of a lactam imide amide 01-06-2011
13. 20100326238 COMPOSITIONS OF MATTER: SYSTEM II - new compositions of matter, particularly metals and alloys, and methods of making such compositions 12-30-2010
14. 20100326237 COMPOSITION OF MATTER TAILORING: SYSTEM I 12-30-2010
15. 20100316607 HEPATITIS C VIRUS INHIBITORS - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 12-16-2010
16. 20100303387 INFLATABLE SHIPPING CONTAINER - inflatable, reusable cargo containing and protecting device suitable for use in shipping, which is inflatable by 12-02-2010
17. 20100276435 STABILIZERS FOR PROPANE CYLINDERS - stabilizer for a pressurized gas cylinder characterized by a cylindrical wall having a diameter d 11-04-2010
18. 20100272811 COMPLEX OF TROSPIUM AND PHARMACEUTICAL COMPOSITIONS THEREOF 10-28-2010
19. 20100266607 ANTIBODY THERAPY FOR USE IN THE DIGESTIVE TRACT 10-21-2010
20. 20100266543 LINKED DIBENZIMIDAZOLE ANTIVIRALS - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 10-21-2010
21. 20100260806 NUCLEIC ACIDS - nucleic acid which comprises a non-specific promoter and at least one sequence that encodes a polypeptide that has at least one 10-14-2010
22. 20100260715 HEPATITIS C VIRUS INHIBITORS - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 10-14-2010
23. 20100252485 Methods and Apparatus for Removal of Degradation Byproducts and Contaminants From Oil for Use in Preparation of Biodiesel 10-07-2010
24. 20100240691 MORPHINAN DERIVATIVES WITH HIGH ORAL BIOAVAILABILITY 09-23-2010
25. 20100239673 Blood compatible nanomaterials and methods of making and using the same 09-23-2010
26. 20100234233 POLYMER HYDROGELS AND METHODS OF PREPARATION THEREOF 09-16-2010
27. 20100233150 REDUCTION OF ADIPOSE TISSUE - The amount of adipose tissue including lipomas at selected locations in the body is reduced by introducing collagenase or 09-16-2010
28. 20100233122 NOVEL BENZIMIDAZOLE DERIVATIVES - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 09-16-2010
29. 20100226883 LINKED DIIMIDAZOLE DERIVATIVES - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 09-09-2010
30. 20100226882 LINKED DIIMIDAZOLE ANTIVIRALS - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 09-09-2010
31. 20100222343 PHOSPHOINOSITIDE 3-KINASE INHIBITORS WITH A ZINC BINDING MOIETY 09-02-2010
32. 20100221216 HEPATITIS C VIRUS INHIBITORS - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 09-02-2010
33. 20100221215 LINKED DIBENZIMIDAZOLE DERIVATIVES - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 09-02-2010
34. 20100221214 LINKED DIBENZIMIDAZOLE DERIVATIVES - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 09-02-2010
35. 20100207358 LASER GUIDED TOWING HITCH ALIGNMENT SYSTEM 08-19-2010
36. 20100203087 CHEMOREPULSION OF CELLS - compositions and methods of controlling the direction and/or movement of migratory cells 08-12-2010
37. 20100196316 CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION 08-05-2010
38. 20100184801 FUSED AMINO PYRIDINES FOR THE TREATMENT OF BRAIN TUMORS 07-22-2010
39. 20100183632 Antibody Therapy For Modulating Function Of Intestinal Receptors 07-22-2010
40. 20100158923 REDUCING POLYGLUTAMINE-BASED AGGREGATION 06-24-2010
41. 20100137435 Monoacetyldiacylglycerol Derivative for the Treatment of Sepsis 06-03-2010
42. 20100135960 ANTIVIRAL ACYLSULFONAMIDE DERIVATIVES - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 06-03-2010
43. 20100129418 METHOD OF INDUCING NEGATIVE CHEMOTAXIS USING AN ELLAGITANNIN OR GALLOTANNIN 05-27-2010
44. 20100111752 COMPOSITION OF MATTER TAILORING: SYSTEM IA 05-06-2010
45. 20100111743 Meshing Surfaces For Intersecting Vanes - toroidal intersecting vane machine incorporating intersecting rotors to form primary and secondary chambers 05-06-2010
46. 20100104587 METHODS OF MODULATING THE NEGATIVE CHEMOTAXIS OF IMMUNE CELLS 04-29-2010
47. 20100096251 Methods and Processes for Attaching Compounds to Matrices 04-22-2010
48. 20100093747 METHOD OF INDUCING NEGATIVE CHEMOTAXIS - The current invention is directed to methods of inducing the negative chemotaxis of a migratory cell comprising 04-15-2010
49. 20100093677 METHOD OF INDUCING NEGATIVE CHEMOTAXIS - The current invention is directed to methods of inducing the negative chemotaxis of a migratory cell comprising 04-15-2010
50. 20100075923 METHOD OF ENHANCING TGF-BETA SIGNALLING - method of enhancing TGF 03-25-2010
51. 20100075864 MEASUREMENT OF COMPLEMENT ACTIVATION PRODUCTS ON ANTIGEN ARRAYS 03-25-2010
52. 20100074889 4'-ALLENE-SUBSTITUTED NUCLEOSIDE DERIVATIVES 03-25-2010
53. 20100074863 ANTI-INFECTIVE PYRROLIDINE DERIVATIVES AND ANALOGS 03-25-2010
54. 20100061972 Method of Treating Peyronie's Disease - The invention is directed to methods of treating patients suffering from Peyronie's disease methods of 03-11-2010
55. 20100046240 DECORATIVE SLEEVE FOR FLAMELESS CANDLE - removable decorative sleeve for wax-surfaced flameless candles comprising a cylindrical open-ended form wherein 02-25-2010
56. 20100041618 6-11 Bridged Oxime Erythromycin Derivatives 02-18-2010
57. 20100029542 PROTEIN STERILISATION BY RADIATION AND ADDITION OF A STABILISING COMPOSITION 02-04-2010
58. 20100028372 STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS 02-04-2010
59. 20100015230 Bone Morphogenetic Protein Compositions - compositions of bone morphogenetic proteins particularly solid and liquid formulations of such proteins 01-21-2010
60. 20100015092 QUINOXALINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 01-21-2010
61. 20100009992 AMPK MODULATORS - compounds and pharmaceutically acceptable salts esters and prodrugs of Formula or : STR00001 which are useful as AMPK modulators 01-14-2010
62. 20100004217 TOPICAL STEROIDAL FORMULATIONS - formulations of poorly water soluble pharmaceutical agents of Formula I and II 01-07-2010
63. 20100003214 QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS 01-07-2010
64. 20090326019 3,4-BICYCLIC PYRROLIDINE ANTIVIRALS - The present invention discloses compounds of formula or pharmaceutically acceptable salts esters 12-31-2009
65. 20090324577 6-11 Bicyclic Ketolide Derivatives - The present invention discloses compounds of formula I or pharmaceutically acceptable salts esters 12-31-2009
66. 20090324544 SUBSTITUTED CYCLIC PYRROLIDINE DERIVATIVES 12-31-2009
67. 20090324537 Polymeric Materials as Stomach Filler and Their Preparation 12-31-2009
68. 20090318649 Styrene-Maleic Anhydride Copolymers for Bioapplications and Their Preparation 12-24-2009
69. 20090318350 PAN-HER ANTAGONISTS AND METHODS OF USE - The present invention features human epidermal receptor antagonists 12-24-2009
70. 20090311783 INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ANTAGONISTS 12-17-2009
71. 20090311235 Use of Polymeric Materials with Other Substances for Improved Performance 12-17-2009
72. 20090306290 Biocompatible, Biodegradable, Water-Absorbent Hybrid Material 12-10-2009
73. 20090305933 LOW INTERFACIAL TENSION SURFACTANTS FOR PETROLEUM APPLICATIONS 12-10-2009
74. 20090304629 MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 12-10-2009
75. 20090286729 Epidermal Growth Factor Receptor Antagonists and Methods of Use 11-19-2009
76. 20090281324 PROCESSES FOR THE PREPARATION OF O-[5-(4-AMINO-THIAZOL-2-YL)-PYRIDIN-2-YLMETHYL]-HYDROXYLAMINE 11-12-2009
77. 20090281293 PROCESSES FOR THE PREPARATION OF 2 FLUORO 6-11 BICYCLIC ERYTHROMYCIN DERIVATIVES 11-12-2009
78. 20090281050 ANTI-BACTERIAL ACTIVITY OF 9-HYDROXY DERIVATIVES OF 6,11-BICYCLOLIDES 11-12-2009
79. 20090275548 COMPOUNDS AND METHODS FOR ACTIVATED THERAPY 11-05-2009
80. 20090274686 NUCLEOSIDE PHOSPHONATE DERIVATIVES - The present invention discloses compounds of formula or or pharmaceutically acceptable salts esters 11-05-2009
81. 20090274657 DIFLUOROMETHYL-CONTAINING MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS 11-05-2009
82. 20090270457 6,11-BICYCLOLIDES: BRIDGED BIARYL MACROLIDE DERIVATIVES 10-29-2009
83. 20090264380 6,11-BRIDGED BIARYL MACROLIDES - The present invention discloses compounds of formula I II or X or pharmaceutically acceptable salts 10-22-2009
84. 20090252814 USE OF XENON FOR ORGAN PROTECTION - Use of xenon is described 10-08-2009
85. 20090238794 FLUORINATED MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS 09-24-2009
86. 20090221702 COMPOUNDS - the use of a compound of the Formula: wherein R 09-03-2009
87. 20090221441 THREE-DIMENSIONAL CELLULAR ARRAY CHIP AND PLATFORM FOR TOXICOLOGY ASSAYS 09-03-2009
88. 20090214650 Methods of Treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers 08-27-2009
89. 20090209758 QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY 08-20-2009
90. 20090209569 SELECTIVE OPIOID COMPOUNDS - compounds of Formula I or II or pharmaceutically acceptable salts 08-20-2009
91. 20090209547 C-8 HALOGENATED MACROLIDES - The present invention discloses compounds of formula or pharmaceutically acceptable salts esters or prodrugs thereof: 08-20-2009
92. 20090206040 SYSTEMS AND METHODS FOR REMOVING FINELY DISPERSED PARTICULATE MATTER FROM A FLUID STREAM 08-20-2009
93. 20090202486 DIFLUORINATED TRIPEPTIDES AS HCV SERINE PROTEASE INHIBITORS 08-13-2009
94. 20090202485 HETEROARYL-CONTAINING TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS 08-13-2009
95. 20090197888 FLUORINATED TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS 08-06-2009
96. 20090191153 OXIMYL MACROCYCLIC DERIVATIVES - compounds of Formula I or pharmaceutically acceptable salts esters 07-30-2009
97. 20090191151 TRIAZOLE-CONTAINING MACROCYCLIC HCV SERINE PROTEASE INHIBITORS 07-30-2009
98. 20090186415 METHOD FOR PRODUCTION OF CYTOCHROME P450 WITH N-TERMINAL TRUNCATED P450 REDUCTASE 07-23-2009
99. 20090180985 BRIDGED CARBOCYCLIC OXIME HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS 07-16-2009
100. 20090180984 MACROCYCLIC OXIMYL HEPATITIS C SERINE PROTEASE INHIBITORS 07-16-2009
101. 20090180983 BICYCLIC, C5-SUBSTITUTED PROLINE DERIVATIVES AS INHIBITORS OF THE HEPATITIS C VIRUS NS3 PROTEASE 07-16-2009
102. 20090175822 C5-SUBSTITUTED, PROLINE-DERIVED, MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 07-09-2009
103. 20090162441 PULMONARY DELIVERY IN TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM 06-25-2009
104. 20090156800 PROCESS FOR MAKING MACROCYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS 06-18-2009
105. 20090156427 Bio-Sensing Nanodevice - comprising: a stabilized biologically-derived G-protein coupled receptor--the olfactory receptor--on a support 06-18-2009
106. 20090155210 OXIMYL HCV SERINE PROTEASE INHIBITORS - The present invention discloses compounds of formula I or pharmaceutically acceptable salts esters 06-18-2009
107. 20090149491 CARBOCYCLIC OXIME HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS 06-11-2009
108. 20090148406 Stable Aqueous Systems Comprising Proteins 06-11-2009
109. 20090143487 Enhanced stability of proteins immobilized on nanoparticles 06-04-2009
110. 20090143403 Methods for Administering Aripiprazole - in part to the discovery that a pharmaceutical composition comprising aripiprazole and a carrier administered 06-04-2009
111. 20090142299 MACROCYCLIC TETRAZOLYL HEPATITIS C SERINE PROTEASE INHIBITORS 06-04-2009
112. 20090136538 Stable vaccine formulation - aqueous vaccine composition comprises a protein adsorbed on a solid and one or more stabilising agents 05-28-2009
113. 20090131343 USE OF BRIDGED MACROLIDES OR TYLOSIN DERIVATIVES IN TREATING INFLAMMATORY BOWEL DISEASES 05-21-2009
114. 20090130059 TETRAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 05-21-2009
115. 20090123570 COMPOSITION AND METHOD FOR TREATING SORE THROAT 05-14-2009
116. 20090123454 METHODS FOR TREATING ADHESIVE CAPSULITIS 05-14-2009
117. 20090123425 MACROCYCLIC, PYRIDAZINONE-CONTAINING HEPATITIS C SERINE PROTEASE INHIBITORS 05-14-2009
118. 20090123423 HYDROXYAMIC ANALOGS AS HEPATITIS C VIRUS SERINE PROTEASE INHIBITOR 05-14-2009
119. 20090118506 6,11-BRIDGED BIARYL MACROLIDES - The present invention discloses compounds of formula I II or or pharmaceutically acceptable salts 05-07-2009
120. 20090112297 Skin Tanning and Light Therapy Incorporating Light Emitting Diodes 04-30-2009
121. 20090111897 REVERSIBLE BIOGEL FOR MANIPULATION AND SEPARATION OF SINGLE-WALLED CARBON NANOTUBES 04-30-2009
122. 20090111772 FORMULATION OF QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY 04-30-2009
123. 20090105201 Pulmonary Pharmaceutical Formulations - improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of 04-23-2009
124. 20090098085 TETRAZOLYL ACYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 04-16-2009
125. 20090093507 CDK INHIBITORS CONTAINING A ZINC BINDING MOIETY 04-09-2009
126. 20090082713 METHOD OF ENHANCING IONTOPHORETIC DELIVERY OF A PEPTIDE 03-26-2009
127. 20090082224 POLYMERS - The application discloses a process for making a polymer having pendant side groups comprising: polymerising an olefinically unsaturated 03-26-2009
128. 20090081061 PERIPHERALLY PIVOTED OSCILLATING VANE MACHINE 03-26-2009
129. 20090076044 VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY 03-19-2009
130. 20090076022 TARTRATE SALTS OF QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY 03-19-2009
131. 20090076006 HSP90 INHIBITORS CONTAINING A ZINC BINDING MOIETY 03-19-2009
132. 20090075915 6,11-BICYCLOLIDES: BRIDGED BIARYL MACROLIDE DERIVATIVES 03-19-2009
133. 20090069547 STABILIZATION OF MAMMALIAN MEMBRANE PROTEINS BY SHORT SURFACTANT PEPTIDES 03-12-2009
134. 20090068274 HIGHLY EFFICIENT DELIVERY OF A LARGE THERAPEUTIC MASS AEROSOL 03-12-2009
135. 20090060874 BICYCLIC PYRROLIDINE DERIVATIVES - The present invention discloses compounds of formula or pharmaceutically acceptable salts esters 03-05-2009
136. 20090054317 POLYVALENT INHIBITORS OF PATHOGENS - polyvalent host cell receptor-directed pathogen inhibitors and methods for designing and using such polyvalent 02-26-2009
137. 20090053175 SUBSTITUTE PYRROLIDINE DERIVATIVES - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 02-26-2009
138. 20090047248 TRIAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 02-19-2009
139. 20090047247 Pyrrolidine Derivatives - The present invention discloses compounds of formula or pharmaceutically acceptable salts esters 02-19-2009
140. 20090041721 ARYLALKOXYL HEPATITIS C VIRUS PROTEASE INHIBITORS 02-12-2009
141. 20090036350 Method for Stabilisation of a Protein Solution by Addition of Hydroxyl Radical Quenchers and its Sterilisation by Ionising Radiation 02-05-2009
142. 20090035272 Pyridazinonyl Macrocyclic Hepatitis C Serine Protease Inhibitors 02-05-2009
143. 20090035271 TETRAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 02-05-2009
144. 20090035268 TETRAZOLYL ACYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 02-05-2009
145. 20090035267 ACYCLIC, PYRIDAZINONE-DERIVED HEPATITIS C SERINE PROTEASE INHIBITORS 02-05-2009
146. 20090022823 Methods for Administering Active Agents to CYP3A4 Sensitive Patients 01-22-2009
147. 20090022689 C4-SPIRO-PYRROLIDINE ANTIVIRALS - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 01-22-2009
148. 20090010918 METHODS FOR TREATMENT USING COLLAGENASE - Methods for treatment by collagenase injections are provided which are effective in dissolving and lysing a 01-08-2009
149. 20090005387 QUINOXALINYL MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS 01-01-2009
150. 20090004140 4-SUBSTITUTED PYRROLIDINE AS ANTI-INFECTIVES 01-01-2009
151. 20080317865 Quench liquids and washing systems for production of microparticles 12-25-2008
152. 20080317712 ARYLPIPERIDINYL AND ARYLPYRROLIDINYL TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS 12-25-2008
153. 20080300348 Polymer - The application provides a method of producing a comb polymer comprising the steps of: Providing: a plurality of monomers which are linear 12-04-2008
154. 20080292587 OXIMYL DIPEPTIDE HEPATITIS C PROTEASE INHIBITORS 11-27-2008
155. 20080287449 AZA-TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS 11-20-2008
156. 20080286233 PIPERIZINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 11-20-2008
157. 20080281075 ASYMMETRIC SYNTHESIS OF PEPTIDES - process comprising substitution of an acceptor molecule comprising a group --XC-- wherein X is O, S or NR 11-13-2008
158. 20080279821 ARYLPIPERIDINYL AND ARYLPYRROLIDINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 11-13-2008
159. 20080274082 OXIMYL HYDROXYAMIC ANALOGS AS HEPATITIS C VIRUS PROTEASE INHIBITOR 11-06-2008
160. 20080274080 AZA-PEPTIDE MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 11-06-2008
161. 20080269228 HYDRAZIDE-CONTAINING HEPATITIS C SERINE PROTEASE INHIBITORS 10-30-2008
162. 20080267918 QUINOXALINYL DIPEPTIDE HEPATITIS C VIRUS INHIBITORS 10-30-2008
163. 20080267917 N-FUNCTIONALIZED AMIDES AS HEPATITIS C SERINE PROTEASE INHIBITORS 10-30-2008
164. 20080267916 CYCLIC P3 TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS 10-30-2008
165. 20080262208 6-11 Bridged Oxime Erythromycin Derivatives 10-23-2008
166. 20080261986 PHARMACEUTICAL FORMULATIONS FOR IONTOPHORETIC DELIVERY OF AN ANTI-FUNGAL DRUG 10-23-2008
167. 20080257713 CATALYTIC REACTORS WITH ACTIVE BOUNDARY LAYER CONTROL 10-23-2008
168. 20080253971 Particles for inhalation having sustained release properties 10-16-2008
169. 20080249339 Charged Polymers for Ethanol Dehydration 10-09-2008
170. 20080248105 POLYMORPHIC FORMS OF 6-11 BICYCLIC KETOLIDE DERIVATIVES 10-09-2008
171. 20080242865 PROCESSES FOR THE PREPARATION OF HYDROXYLAMINES 10-02-2008
172. 20080241253 Formulations for Spray-Drying Large Porous Particles 10-02-2008
173. 20080234629 WATER ELECTROLYSIS TO FACILITATE DRUG DELIVERY BY IONTOPHORESIS 09-25-2008
174. 20080234355 DNA METHYL TRANSFERASE INHIBITORS CONTAINING A ZINC BINDING MOIETY 09-25-2008
175. 20080234332 RAF KINASE INHIBITORS CONTAINING A ZINC BINDING MOIETY 09-25-2008
176. 20080234314 FUSED AMINO PYRIDINE AS HSP90 INHIBITORS 09-25-2008
177. 20080234297 HSP90 Inhibitors Containing a Zinc Binding Moiety 09-25-2008
178. 20080233614 PRODUCTION OF RECOMBINANT COLLAGENASES COLG AND COLH IN ESCHERICHIA COLI 09-25-2008
179. 20080233199 Coacervation Process - Methods of forming compositions for the sustained release of water soluble active agents including biologically active 09-25-2008
180. 20080227804 Polymorphic Forms of Naltrexone - This invention relates to the discovery of novel polymorphic forms of naltrexone including solvates 09-18-2008
181. 20080227690 PARTICLES FOR INHALATION HAVING RAPID RELEASE PROPERTIES 09-18-2008
182. 20080226730 PARTICLES FOR INHALATION HAVING RAPID RELEASE PROPERTIES 09-18-2008
183. 20080221132 Multi-Functional Small Molecules as Anti-Proliferative Agents 09-11-2008
184. 20080217013 TUNABLE SURFACTANTS FOR OIL RECOVERY APPLICATIONS 09-11-2008
185. 20080213319 CHEMOREPULSION OF CELLS - compositions and methods of controlling the direction and/or movement of migratory cells 09-04-2008
186. 20080200543 Immunomodulating Agent, Anti-Cancer Agent and Health Food Containing Monoacetyldiacylglycerol Derivatives 08-21-2008